We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCAP
1801
DELISTED
Harvest Capital Credit Corporation
HCAP
– –
-35
Closed –
WIFI
1802
DELISTED
Boingo Wireless, Inc.
WIFI
– –
-243,328
Closed -$5.67M
BXG
1803
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
– –
-315
Closed -$5K
WDR
1804
DELISTED
Waddell & Reed Financial, Inc.
WDR
– –
-1,500
Closed -$26K
EGOV
1805
DELISTED
NIC Inc
EGOV
– –
-43,850
Closed -$751K
IPHI
1806
DELISTED
INPHI CORPORATION
IPHI
– –
-700
Closed -$30K
PS
1807
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
– –
-23,709
Closed -$753K
HPR
1808
DELISTED
HighPoint Resources Corporation
HPR
– –
-223
Closed -$25K
UROV
1809
DELISTED
Urovant Sciences Ltd.
UROV
– –
-4,902
Closed -$49K
QEP
1810
DELISTED
QEP RESOURCES, INC.
QEP
– –
-44,800
Closed -$349K
RLH
1811
DELISTED
Red Lions Hotel Corporation
RLH
– –
-1,265
Closed -$10K
CZZ
1812
DELISTED
Cosan Limited
CZZ
– –
-310,912
Closed -$3.6M
ACIA
1813
DELISTED
Acacia Communications Inc
ACIA
– –
-38,247
Closed -$2.19M
CXO
1814
DELISTED
CONCHO RESOURCES INC.
CXO
– –
-12,283
Closed -$1.36M
FIT
1815
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-10,549
Closed -$62K
BMCH
1816
DELISTED
BMC Stock Holdings, Inc
BMCH
– –
-13,934
Closed -$246K
TCO
1817
DELISTED
Taubman Centers Inc.
TCO
– –
-700
Closed -$37K
HUD
1818
DELISTED
Hudson Ltd. Class A Common Shares
HUD
– –
-40,072
Closed -$551K
YGYI
1819
DELISTED
Youngevity International, Inc Common Stock
YGYI
– –
-2,869
Closed -$16K
MYOK
1820
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-252,612
Closed -$13.1M
MR
1821
DELISTED
Montage Resources Corporation Common Stock
MR
– –
-2,077
Closed -$31K
BITA
1822
DELISTED
Bitauto Holdings Limited
BITA
– –
-2,200
Closed -$35K
RST
1823
DELISTED
ROSETTA STONE INC
RST
– –
-19,675
Closed -$430K
AIMT
1824
DELISTED
Aimmune Therapeutics
AIMT
– –
-1,418
Closed -$32K
ONDK
1825
DELISTED
On Deck Capital, Inc.
ONDK
– –
-900
Closed -$5K
71 72
73
74 75

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.